期刊
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
卷 45, 期 4, 页码 569-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2019.07.006
关键词
Myositis; Treatment; Target; Criteria; Autoantibodies; Exercise
类别
资金
- Czech Ministry of Health Conceptual Development of Research Organization [00023728]
- Czech Health Research Council [16-33746A]
- Swedish Research Council [2016-01254]
- Swedish Rheumatism Association
- Stockholm County Council
- Karolinska Institutet
- Swedish Research Council [2016-01254] Funding Source: Swedish Research Council
Major advances have been made in the field of idiopathic inflammatory myopathies (IIM), or myositis, that are likely to facilitate development of new therapeutic strategies that have not yet been applied in this group of diseases. These advances include new classification criteria to better identify the patients with IIM, detection of several new myositis-specific autoantibodies that facilitates subgrouping of patients into more specific clinical phenotypes, development of outcome measures for disease activity, and new response criteria. We have learned from clinical studies that exercise is an important part of treatment and that pharmacologic treatment should be combined with exercise.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据